BID Equity acquires AB CUBE, a leading software provider for pharmaceutical product safety 

AB CUBE, 13 Jan 2022

BID Equity Fund II, advised by BID Equity, has acquired AB CUBE, SAS based in Paris, an established provider of multivigilance software in the pharmaceutical and cosmetics sectors.

With its SafetyEasy® Suite, AB CUBE offers its customers a simple and regulatory-compliant solution for reporting and processing vigilance processes. In addition to the recording of adverse reactions for combination products, AB CUBE covers a variety of other areas, such as biovigilance or cosmetovigilance. This combination offers manufacturers and marketing authorization holders the possibility to standardize their vigilance processes across different product areas and to ensure permanent compliance with the regulatory requirements of FDA, EMA and MHRA. More than 2000 users in over 43 countries currently manage their vigilance processes with the AB CUBE SafetyEasy® Suite.

With AB CUBE as the cornerstone, the development of a new group of companies in the field of medical, pharmaceutical and cosmetic regulatory and safety processes begins. The objective is to build a provider that covers all relevant international regulatory compliance – incl. vigilance – needs. AB CUBE Managing Director Matthieu Doresse emphasizes: "BID Equity's expertise both in software development and clinical research processes makes them a perfect partner to accelerate the internationalization of AB CUBE. I look forward to jointly build the leading software provider for regulatory affairs in the medical space in Europe."


BID Equity acquires Kobold, a leading software provider for architects and engineering firms


JustRelate Group acquires Planware, a provider of product configuration software

More News about new Groups

06 Aug 2020

BID Equity Fund II, a fund advised by BID Equity, acquires the majority of Infopark Group GmbH. Infopark is the manufacturer of the web-based Content Management Software Scrivito.

12 Sep 2019

BID Equity Fund II, a fund advised by BID Equity, acquires a majority stake in XClinical GmbH. XClinical is a leading international provider of software solutions for drug and medical device studies.

28 Jun 2018

BID Equity has acquired 100% of eSight Energy Group Ltd’s shares. eSight Energy is a global energy management software developer and solutions provider. The transaction was closed in April ’18.

07 Jan 2018

In December 2017 German software investor BID Equity has simultaneously acquired majority stakes in the Dutch Regas Group and German Heimbas GmbH.